News

Filter

Current filters:

Research

176 to 185 of 96543 results

Regeneron gains further FDA indications for Eylea

Regeneron gains further FDA indications for Eylea

07-10-2014

The US Food and Drug Administration has approved biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

New UK human studies funded by £60 million investment to research Parkinson’s, addiction and immunity

New UK human studies funded by £60 million investment to research Parkinson’s, addiction and immunity

07-10-2014

Three new research programs have been funded as part of a £60 million ($96 million) investment from…

NeurologicalPharmaceuticalResearchUKUnited Kingdom

Islet and BHV sign licensing agreement for diabetes drug in development

Islet and BHV sign licensing agreement for diabetes drug in development

06-10-2014

Metabolic biopharma specialist Islet Sciences says that its merger partner, Brighthaven Ventures (BHV…

BHVBrazilBrighthaven VenturesDiabetesIslet SciencesLicensingPharmaceuticalremogliflozin

Actavis to acquire Durata Therapeutics for $675 million

Actavis to acquire Durata Therapeutics for $675 million

06-10-2014

In a move that takes it further out of its main generics business, Ireland-headquartered Actavis has…

ActavisAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsIrelandMergers & AcquisitionsPharmaceutical

Mylan debuts generic of ViiV’s Combivir in USA

Mylan debuts generic of ViiV’s Combivir in USA

06-10-2014

US generic drugmaker Mylan has launched of its Lamivudine and Zidovudine Tablets USP, 15mg/300mg, which…

Anti-viralsCombivirGenericsGlaxoSmithKlineMarkets & MarketingMylanUSAViiV Healthcare

Cipla in deal to set up a manufacturing unit in Iran

Cipla in deal to set up a manufacturing unit in Iran

06-10-2014

Indian drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing…

CiplaIranMergers & AcquisitionsPharmaceuticalProduction

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

06-10-2014

French company CleveXel Pharma has been granted a license by the SATT Sud Est, a technology transfer…

BiotechnologyCleveXel PharmaFranceLicensingOncologyPatentsSATT Sud Est

AbbVie gains expanded approval for Humira by FDA

AbbVie gains expanded approval for Humira by FDA

06-10-2014

US drugmaker AbbVie has received approval from the US Food and Drug Administration for an extension of…

AbbVieAnti-Arthritics/RheumaticsHumiraPharmaceuticalRegulationUSA

176 to 185 of 96543 results

Parexel

Parexel

Back to top